The next logical question: If GLP-1 could stimulate the release of insulin, which lowered the level of glucose in the bloodstream, could GLP-1 form the basis of a new treatment for diabetes
"If they regain weight later, their body composition worsens," he adds, noting that this "yo-yo cycle" of losing and regaining "raises the long-term risk of weight gain," especially when cycling on and off the medication
202210 (WileyBlackwell, 2011)
The clinical signal is now catching up to what the rodent data has been saying for a decade
However, the aforementioned study involved only 20 subjects who self-applied skin products and overall the study methodology was highly questionable
Two practical points follow